DUBLIN–(BUSINESS WIRE)–The “North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis (2018-2024)” report has been added to ResearchAndMarkets.com’s offering. The North America Minimally Invasive Glaucoma Surgery (MIGS) Devices…
Author: Business Wire
Ophthalmic Viscosurgical Devices Market: Global Industry Perspective, Comprehensive Analysis and Forecast (2017-2023) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Viscosurgical Devices Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017-2023” report has been added to ResearchAndMarkets.com’s offering. The report covers forecast and analysis for …
Ocular Therapeutix™ to Present at the 30th Annual Piper Jaffray Healthcare Conference
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Anto…
Minimally Invasive Glaucoma Surgery (MIGS) Devices – Global Market Trends & Opportunities to 2024: A $1.18 Billion Opportunity – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis (2018-2024)” report has been added to ResearchAndMarkets.com’s offering. The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market size i…
Permanent J Code Issued for Avedro’s Photrexa® Drug Formulations
WALTHAM, Mass.–(BUSINESS WIRE)–Avedro, Inc., a leading commercial-stage ophthalmic medical technology company and a global leader in corneal remodeling, today announced that the Centers for Medicare and Medicaid Services (CMS) issued a product-specif…
Global Contact Lens Market with Focus on Soft Contact Lens: Industry Analysis & Outlook (2018-2022) – Johnson & Johnson, Bausch Health Companies, The Cooper Companies, and Novartis are Dominating – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Contact Lens Market with Focus on Soft Contact Lens- Industry Analysis & Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering. The global contact lens market was rapidly growing in 2017, w…
Eye Care Surgical Market – Global Analysis & Forecast 2018-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eye Care Surgical Market Analysis 2018 – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. The report contains up to date financial data derived from varied research sources to present un…
Affordable Designer Prescription Eyewear from Warby Parker Now Available to People Enrolled in UnitedHealthcare Medicare Advantage Plans
MINNETONKA, Minn.–(BUSINESS WIRE)–Warby Parker’s designer prescription eyewear is now available to approximately 2 million people enrolled in UnitedHealthcare Medicare Advantage plans.
Global Optogenetics Actuators and Sensors Market by Product and Disease Type – Outlook Through 2018-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optogenetics Actuators and Sensors Market Analysis Report By Product, By Disease Type (Retinal Disorders, Parkinson’s Disease, Schizophrenia, Autism, Depression & Anxiety), And Segment Forecasts, 2018 – 2025” report has be…
Georgia Eye Associates Affiliates with EyeSouth Partners
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed a strategic partnership with Georgia Eye Associates, expanding its presence into the Lawrenceville and northeast Atlanta regions. Eye…
Global Retinal Implant Market Size, Share & Trends Analysis Report by Device Type (Retina Implant Alpha AMS, Implantable Miniature Telescope, and Argus II) and Region (2018-2026) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Implant Market Size, Share & Trends Analysis Report By Device Type (Retina Implant Alpha AMS, Implantable Miniature Telescope, and Argus II), By Region, And Segment Forecasts, 2018 – 2026” report has been added to …
4D Molecular Therapeutics Announces FDA Orphan Drug Designation Granted to 4D-110 for the Treatment of Choroideremia
EMERYVILLE, Calif.–(BUSINESS WIRE)–4D Molecular Therapeutics (4DMT), a world-leader in Therapeutic Vector Evolution for adeno-associated virus (AAV) gene therapy vector discovery and product development today announced that the U.S. Food and Drug Adm…
Glaukos Announces Participation in Piper Jaffray Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
NovaBay Pharmaceuticals Reports Third Quarter 2018 Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NBY 3Q18 Financial Results
AJMC® Researchers Have 3 Suggestions to Close the Gaps When Creating Value Frameworks for New Medical Therapies
CRANBURY, N.J.–(BUSINESS WIRE)–AJMC Researchers Have 3 Suggestions to Close the Gaps When Creating Value Frameworks for New Medical Therapies
AsclepiX Therapeutics Raises $5M in New Funding
BALTIMORE–(BUSINESS WIRE)–AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on developing vital new therapies based on a novel peptide platform, today announced that it has raised $5 million in Convertible Note funding, led by Barer & …
ams: Miniature, high-resolution CMOS image sensors create new potential for single-use, high-performance endoscopes
PREMSTAETTEN, Austria–(BUSINESS WIRE)–ams announces pre-release of NanEyeM and NanEyeXS Micro Camera Modules for medical imaging applications and minimally invasive surgery
Global Optometry/Eye Examination Equipment Market Analysis Report 2018-2025 By End Use (Hospitals, Clinics), Product (Ophthalmic Ultrasound Imaging Systems, OCT), Region and Segment Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optometry/Eye Examination Equipment Market Analysis Report By End Use (Hospitals, Clinics), By Product (Ophthalmic Ultrasound Imaging Systems, OCT), By Region, And Segment Forecasts, 2018 – 2025” report has been added to R…
Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration
NEW YORK–(BUSINESS WIRE)–Ophthotech announced the results from its Phase 2a safety trial of Zimura® in patients with wet age-related macular degeneration (AMD).
Acucela Initiates Phase 3 Study of Emixustat Addressing Patients with Stargardt Disease
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that on November 7, 2018, the first patient has enrolled (F…